Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,215
+$86,292 QoQ
Shares Held
2,747
+447.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#188
of 252 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,724 across 427 Biotechnology names. CLDX ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in CLDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,215 | 2,747 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,923 | 502 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $62,249 | 2,292 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,174,523 | 45,401 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,030,013 | 50,615 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $10,234 | 564 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $76,567 | 3,030 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $263,523 | 7,753 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $245,227 | 6,626 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $78,525 | 1,871 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $594,303 | 14,985 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $213,775 | 7,768 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $170,294 | 5,019 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $93,978 | 2,612 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $239,828 | 5,381 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,668 | 593 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,140 | 302 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $96,355 | 2,829 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $368,779 | 9,544 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $280,045 | 5,187 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $89,752 | 2,684 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $4,292 | 245 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $192 | 13 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,536 | 272 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,368 | 1,427 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||